Position history for RA CAPITAL MANAGEMENT, L.P.'s holdings in RHYTHM PHARMACEUTICALS INC
RA CAPITAL MANAGEMENT, L.P. holds 6.7M shares of RYTM (RHYTHM PHARMACEUTICALS INC), worth $579.8M as of 2026-Q1. RYTM represents 6.1% of RA CAPITAL MANAGEMENT, L.P.'s portfolio.
Current Value
$579.8M
Current Shares
6.7M
Total Value Change
+$330M
Total Shares Change
+582,425
Other major holders of RYTM: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BlackRock, Inc.
Unchanged |
| 6.7M |
0.0% |
| $579.8M |
| 6.1% |
| $89.56 |
0 |
| 2025-Q4 | Increased | 6.7M | +17.4% | $713.6M | 7.3% | $106.76 | 72 |
| 2025-Q3 | Increased | 5.7M | +2.2% | $573.8M | 7.1% | $100.64 | 62 |
| 2025-Q2 | Decreased | 5.6M | -8.6% | $351.4M | 5.9% | $62.73 | 0 |
| 2025-Q1 | Unchanged | 6.1M | 0.0% | $322.3M | 5.4% | $54.80 | 0 |
| 2024-Q4 | Unchanged | 6.1M | 0.0% | $340.6M | 4.5% | $56.34 | 0 |
| 2024-Q3 | Unchanged | 6.1M | 0.0% | $318.8M | 3.7% | $51.35 | 0 |
| 2024-Q2 | Increased | 6.1M | +14.2% | $249.8M | 3.3% | $41.06 | 64 |